Selectquote Inc Stock Price, News & Analysis

SelectQuote, Inc. (NYSE: SLQT) announces the departure of CFO Raff Sadun after five years, effective at the end of the month. Ryan Clement, SVP of Financial Planning & Analysis, will serve as interim CFO during the search for a permanent replacement. Sadun played a key role during the company’s IPO in 2020 and contributed significantly to its finance function. CEO Tim Danker expressed gratitude for Sadun's contributions to the company's growth. SelectQuote specializes in insurance solutions and has expanded its operations in recent years, including healthcare services.

SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue of $275.1 million for Q3 FY2022, an increase from $265.3 million in Q3 FY2021. The company experienced a net loss of $6.4 million compared to a net income of $35.2 million in the prior year. Adjusted EBITDA was $13.0 million, down from $63.6 million year-over-year. The company maintained its full-year guidance for revenue, expecting between $810 million and $850 million with a net loss range of $255 million to $236 million.

SelectQuote (NYSE: SLQT) will announce its fiscal Q3 2022 financial results on May 5, 2022, before market opening. CEO Tim Danker and CFO Raff Sadun will discuss the results in a conference call at 8:30 AM ET the same day. SelectQuote, established in 1985, offers unbiased insurance comparisons from reputable carriers, helping consumers protect their families and assets. It operates through three main divisions: Senior, Life, and Auto & Home. The company is focused on serving a rapidly aging demographic, particularly in Medicare-related services.

SelectQuote, Inc. (NYSE: SLQT) has formed a strategic partnership with a leading hearing benefits provider to launch the SelectHearing program. This initiative aims to provide affordable hearing healthcare and hearing aid options to members of Population Health. The partnership aligns with recent FDA efforts to enhance access to hearing aids, addressing untreated hearing loss which has been linked to significantly higher healthcare costs. The program is expected to improve health outcomes for consumers, particularly among older adults who often experience hearing limitations.

SelectQuote (NYSE: SLQT) has established a new Healthcare Advisory Board to enhance its Population Health strategy. This board comprises experts from various healthcare sectors, aimed at improving consumer engagement and reducing healthcare costs. Notable members include Dr. Kavita Patel and Earl Devanny, along with several distinguished professionals from the healthcare domain. The board will provide strategic insights and recommendations to strengthen Population Health services, signaling a commitment to innovation and better health outcomes.

SelectQuote, Inc. (SLQT) reported a consolidated revenue of $195.0 million for Q2 FY2022, down from $357.6 million in the same quarter last year. The company faced a net loss of $137.0 million, compared to a net income of $89.9 million a year ago. Adjusted EBITDA was $(163.3) million. Full-year guidance expects revenue between $810 million to $850 million and a net loss of $255 million to $236 million. The Senior segment experienced a notable decline in revenue and profitability due to market challenges.

On February 7, 2022, SelectQuote (NYSE: SLQT) will release its fiscal Q2 2022 financial results after market close. CEO Tim Danker and CFO Raff Sadun will host a conference call at 5:00 PM ET on the same day to discuss these results. The release will detail performance metrics and future outlook, catering to investors seeking insights into the company's growth trajectory. SelectQuote is known for providing consumers with unbiased insurance comparisons, with a strong focus on Medicare solutions as its fastest-growing segment.

SelectQuote, Inc. (NYSE: SLQT) reported a consolidated revenue of $159.9 million for Q1 FY2022, a 29% increase year-over-year. However, the company faced a net loss of $45.4 million, compared to a net income of $0.8 million in the previous year. The Senior segment saw revenues of $106.3 million (up 45% YoY), but Adjusted EBITDA was $(44.0) million, down from $12.1 million. The Auto & Home segment also declined 22% in revenue, highlighting mixed performance across sectors.

BrainCheck, a cognitive healthcare platform, has raised $10 million in Series B funding led by Next Coast Ventures and S3 Ventures, bringing total capital to $20 million. Strategic investors UPMC Enterprises and SelectQuote will help enhance R&D and market capabilities. BrainCheck aims to improve cognitive health care accessibility by enabling primary care physicians to conduct quick cognitive assessments. The platform addresses the growing issue of cognitive impairment, particularly among seniors, with a 10- to 15-minute test covered by Medicare.